After Serum Institute, Bharat Biotech has announced that it will sell its Covid-19 vaccine, Covaxin at Rs. 600 to state hospitals and at Rs. 1,200 to private hospitals. The company said that it will export the vaccine at $15-20 per dose.
“Bharat Biotech is honoured to develop, manufacture and supply Covaxin for India’s vaccine rollout at Rs 150 per dose, which is distributed for free by the Government of India. We would like to state that more than 50% of our capacities have been reserved for central government supplies,” it added.
Managing Director and Chairman of Bharat Biotech, Krishna Ella said, “Recovering costs is essential in the journey of innovation towards other vaccines such as intranasal COVID-19, chikungunya, zika, cholera and others. Our core mission for the last 25 years has been to provide affordable yet world class healthcare solutions for the globe.”
In recent years, diet and lifestyle have been recognized as crucial factors influencing cancer risk.…
Surgical advancements have evolved significantly over the decades, leading to improved precision, reduced recovery time,…
A tragic incident in northwest Delhi has sparked a medical negligence controversy after a 20-year-old…
Maharashtra is set to witness a significant transformation in its public health sector with the…
Sleep is essential for overall health, yet many people suffer from sleep disorders that disrupt…
Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…